Shasun Pharmaceuticals has informed the BSE that the company’s board will meet on June 8 to consider conversion of 71 lakh convertible warrants issued to Sequent Scientific, Mumbai, on preferential basis, to equity shares. In view of this, the trading window for equity shares will be closed for directors and designated employees of the company from Tuesday to June 10.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.